Blog Precision Partnerships Linkedin Twitter Facebook Precision Partnerships: Accelerating Clinical Trials for Emerging Biopharma Through Deep Site Relationships and Smart Technology Executive Summary Over 80% of clinical trials struggle with patient recruitment, and emerging biopharma sponsors face mounting pressure to execute faster, smarter trials while

Blog: DID YOU KNOW… The FDA has release THREE new draft guidances aimed at increasing diversity to cancer clinical trials? Linkedin Twitter Facebook Eligibility criteria for cancer clinical trials are often highly restrictive, raising the question:  are all these restrictions necessary or can they be

Blog DID YOU KNOW…C3TI Linkedin Twitter Facebook  DID YOU KNOW…there’s a new hub for advancing clinical trial innovation – C3TI? Created by the Center of Drug Evaluation and Research (CDER),  C3TI or CDER Center for Clinical Trial Innovation, serves as a central platform for internal

Navigating IRB Approvals Key Insights Linkedin Twitter Facebook In the realm of clinical research, IRB approvals are pivotal. Here are some crucial points worth knowing: Determinants of Approval The IRB bases its approval on either “Societal Benefit” or “Scientific Benefit”. The aim of clinical research

Partnering with Women-Owned Businesses Empowering Progress with ProTrials Research, Inc. Linkedin Twitter Facebook In the dynamic world of clinical research, innovation and diversity are essential drivers of progress. At ProTrials, we recognize the significance of fostering diversity and embracing innovative approaches to advance the field

Blog: Did you know some concerns about decentralized trials may not be warranted? Linkedin Twitter Facebook As more Sponsors think about trying ‘decentralized’ trials, some remain concerned about how well they will actually ‘work’.  Decentralized trials are not what we are used to.  They do

Blog 5 Key Factors to Consider When Choosing a CRO for Your Clinical Trial Linkedin Twitter Facebook Clinical trials are critical to bringing new treatments and cures to patients. However, successfully conducting a clinical trial requires extensive expertise, resources, and attention to detail. That’s why

Blog Making the case for small to mid-sized CROs Linkedin Twitter Facebook In the field of clinical research drug development, markers strongly point to continued expansion and growth of the CRO industry as an outsourcing arm of pharmaceutical companies. According to a recent market research

Blog: Site Selection How do you find the right sites for your clinical study? Linkedin Twitter Facebook The world has changed a lot in the last 18 or so months. The COVID pandemic caused us to rethink the way we do a lot of things.

Promoting Diversity in Clinical Trials Linkedin Twitter Facebook Diseases can impact different population groups unequally. The recent coronavirus proved to be no exception. In the U.S., COVID-19 had a devastating impact in particular on BIPOC (Black, Indigenous, and people of color) communities.[1]  The race to

ProTrials Celebrates 25 Years Linkedin Twitter Facebook May 2021, marks the 25th anniversary of ProTrials Research, Inc., a 100% woman owned full-service clinical research organization (CRO) headquartered in the United States, with clinical operations personnel located throughout North America and worldwide. Since our launch in

DID YOU KNOW? There’s an FDA guidance available for COVID-related questions. Linkedin Twitter Facebook There is no doubt COVID has changed the face of clinical research.  At last count, there were no fewer than 65 FDA guidances related to COVID.  Initially information was sparse. We

Remote Monitoring How Remote Monitoring Has Evolved during COVID Linkedin Twitter Facebook If we weren’t working remotely before March 2020, odds are we had to start. Some of us were more prepared to ‘go virtual’ than others. Prior to COVID, there may have been occasional